Paul Ashley Joins the APBD Research Foundation’s Board of Directors
June 15th, 2023
The APBD Research Foundation is delighted to announce that Paul Ashley has joined the Board of Directors.
Paul is based in Calgary and has more than 25 years of sales and account management experience.
“We are thrilled to welcome Paul to the Board of Directors. He brings extensive business development and strategic communications skills and his personal journey with APBD,” said co-founder and co-president Emil Weiss.
Weiss added, “Growing our Board of Directors is an important part of our strategic plan. We look forward to working with Paul in this new capacity.”
Paul was misdiagnosed for many years before learning that APBD was the cause of the many symptoms he was experiencing. By connecting with the Foundation, Paul met other patients while learning about better managing his symptoms and the treatment potential that the research suggests.
Paul shared, “I am honored to join such an impactful team and will strive to support the Foundation’s mission in any way I can. I want to reduce the diagnostic odyssey of other patients, and, of course, see treatments for all of us facing APBD.”
Please join us in warmly welcoming Paul to the ABPDRF Board of Directors!
News Releases
We are thrilled to announce that our community raised an incredible $201,177 during the 2026 APBD Tour de Friends Rally for Research fundraising campaign, exceeding our original goal of $120,000.
The Academy of General Dentistry (AGD) recently awarded the APBD Research Foundation's co-president Dr. Jeff Levenson with the Lifelong Learning & Service Recognition (LLSR). He received this award along with 36 other LLSR recipients during the AGD’s scientific session in Las Vegas, NV on June 27, 2026.
In April 2026, the APBD Research Foundation announced participant recruitment for its APBDRF Drug Repurposing Study initiative in partnership with COMBINEDBrain. We are grateful to the patients and families in our community that have volunteered to provide biosamples to help make this study a reality.
The APBD Research Foundation is pleased to announce the third of our 2025 Rally for Research Pilot Grant Program grant recipients: Rebecca Koch, PhD, RDN at Duke University. Her research project is entitled, Gene Therapy to Treat the Neurophenotype of Glycogen Storage Disease Type IV.
The APBD Research Foundation is pleased to announce the second of our 2025 Rally for Research Pilot Grant Program grant recipients: Mayank Verma, MD, PhD at UTSW Medical Center. His research project is entitled Preclinical Validation and Biomarkers in APBD of a GYS1-ASO Currently in Phase 1 Clinical Trial for Lafora Disease
On behalf of the APBD community, the APBD Research Foundation has responded to the US Food and Drug Administration's (FDA) request for public comments for its recently released draft guidance for the use of the Plausible Mechanism Framework for individualized genetic therapies.
We are excited to launch the 2026 APBD Tour de Friends Rally for Research Fundraising Campaign to raise $150,000.
The APBD Research Foundation is excited to announce an opportunity for you to play a direct role in advancing treatment research. You do not have to leave home to participate.
The APBD Research Foundation is delighted to announce the appointment of Carol Rosenstock to its Board of Directors.